Pharma Nordic ApS: Financial statements 2022
CVR: 37842338
Source: annual report 2022, Danish Business Authority
01/10/2021 – 30/09/2022
Pharma Nordic ApS (CVR 37842338) has filed annual accounts for 2022. In 2022, the company reported revenue of DKK 52,300 and a net result of DKK -109,756 compared with DKK 300,211 the year before. That is a decrease of 85.7% compared with the year before. The profit margin was -209.9%. Equity in the 2022 report amounted to DKK 876,319. The solvency ratio was 87.4%.
- Revenue
- DKK 52,300
- Gross Profit
- DKK -107,650
- Profit/Loss
- DKK -109,756
- Equity
- DKK 876,319
- Total Assets
- DKK 1,002,853
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2022 | 52 t. | -108 t. | -110 t. | 876 t. | - |
| 2021 | 366 t. | 322 t. | 300 t. | 1 mio. | 0 |
| 2020 | 26 t. | -102 t. | -140 t. | 725 t. | - |
| 2018 | 42 t. | -42 t. | -64 t. | 644 t. | - |
Official annual report
Keep an eye on Pharma Nordic ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringAbout Pharma Nordic ApS
Pharma Nordic ApS is a Danish company of the type Anpartsselskab based in Skanderborg, founded in 2016. The company is registered under the industry Anden udlejning af boliger. The management consists of Niels Skovmand Juhl. The company is owned by Niels Skovmand Juhl, Christopher Skovmand Møller Juhl and Stephanie Skovmand Møller Juhl. According to the 2021 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK 0 and a net result of DKK 0 compared with DKK -5,137 the year before. Equity in the 2025 report amounted to DKK -23,687.